These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 22607309)
1. Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation. Tomašić T; Peterlin Mašič L Expert Opin Drug Discov; 2012 Jul; 7(7):549-60. PubMed ID: 22607309 [TBL] [Abstract][Full Text] [Related]
2. Rhodanine as a privileged scaffold in drug discovery. Tomasić T; Masic LP Curr Med Chem; 2009; 16(13):1596-629. PubMed ID: 19442136 [TBL] [Abstract][Full Text] [Related]
3. Recent developments with rhodanine as a scaffold for drug discovery. Kaminskyy D; Kryshchyshyn A; Lesyk R Expert Opin Drug Discov; 2017 Dec; 12(12):1233-1252. PubMed ID: 29019278 [TBL] [Abstract][Full Text] [Related]
4. Privileged scaffolds or promiscuous binders: a comparative study on rhodanines and related heterocycles in medicinal chemistry. Mendgen T; Steuer C; Klein CD J Med Chem; 2012 Jan; 55(2):743-53. PubMed ID: 22077389 [TBL] [Abstract][Full Text] [Related]
5. In silico discovery and biophysical evaluation of novel 5-(2-hydroxybenzylidene) rhodanine inhibitors of DNA gyrase B. Brvar M; Perdih A; Hodnik V; Renko M; Anderluh G; Jerala R; Solmajer T Bioorg Med Chem; 2012 Apr; 20(8):2572-80. PubMed ID: 22444877 [TBL] [Abstract][Full Text] [Related]
6. Discovery of novel 5-benzylidenerhodanine and 5-benzylidenethiazolidine-2,4-dione inhibitors of MurD ligase. Zidar N; Tomasić T; Sink R; Rupnik V; Kovac A; Turk S; Patin D; Blanot D; Contreras Martel C; Dessen A; Müller Premru M; Zega A; Gobec S; Peterlin Masic L; Kikelj D J Med Chem; 2010 Sep; 53(18):6584-94. PubMed ID: 20804196 [TBL] [Abstract][Full Text] [Related]
7. Drug screening of rhodanine derivatives for antibacterial activity. Maddila S; Gorle S; Jonnalagadda SB Expert Opin Drug Discov; 2020 Feb; 15(2):203-229. PubMed ID: 31777321 [No Abstract] [Full Text] [Related]
8. A conceptual review of rhodanine: current applications of antiviral drugs, anticancer and antimicrobial activities. Mousavi SM; Zarei M; Hashemi SA; Babapoor A; Amani AM Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1132-1148. PubMed ID: 30942110 [TBL] [Abstract][Full Text] [Related]
9. Catechol-rhodanine derivatives: Specific and promiscuous inhibitors of Escherichia coli deoxyxylulose phosphate reductoisomerase (DXR). Zinglé C; Tritsch D; Grosdemange-Billiard C; Rohmer M Bioorg Med Chem; 2014 Jul; 22(14):3713-9. PubMed ID: 24890653 [TBL] [Abstract][Full Text] [Related]
10. Discovery of potent and selective rhodanine type IKKβ inhibitors by hit-to-lead strategy. Song H; Lee YS; Roh EJ; Seo JH; Oh KS; Lee BH; Han H; Shin KJ Bioorg Med Chem Lett; 2012 Sep; 22(17):5668-74. PubMed ID: 22858099 [TBL] [Abstract][Full Text] [Related]
11. Rhodanine-based PRL-3 inhibitors blocked the migration and invasion of metastatic cancer cells. Min G; Lee SK; Kim HN; Han YM; Lee RH; Jeong DG; Han DC; Kwon BM Bioorg Med Chem Lett; 2013 Jul; 23(13):3769-74. PubMed ID: 23726031 [TBL] [Abstract][Full Text] [Related]
12. 5-benzylidenerhodanine and 5-benzylidene-2-4-thiazolidinedione based antibacterials. Zvarec O; Polyak SW; Tieu W; Kuan K; Dai H; Pedersen DS; Morona R; Zhang L; Booker GW; Abell AD Bioorg Med Chem Lett; 2012 Apr; 22(8):2720-2. PubMed ID: 22444680 [TBL] [Abstract][Full Text] [Related]
14. The Importance of Rhodanine Scaffold in Medicinal Chemistry: A Comprehensive Overview. Mermer A Mini Rev Med Chem; 2021; 21(6):738-789. PubMed ID: 33334286 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of new chalcone derivatives containing a rhodanine-3-acetic acid moiety with potential anti-bacterial activity. Chen ZH; Zheng CJ; Sun LP; Piao HR Eur J Med Chem; 2010 Dec; 45(12):5739-43. PubMed ID: 20889240 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of rhodanine derivatives as PRL-3 inhibitors. Ahn JH; Kim SJ; Park WS; Cho SY; Ha JD; Kim SS; Kang SK; Jeong DG; Jung SK; Lee SH; Kim HM; Park SK; Lee KH; Lee CW; Ryu SE; Choi JK Bioorg Med Chem Lett; 2006 Jun; 16(11):2996-9. PubMed ID: 16530413 [TBL] [Abstract][Full Text] [Related]
17. 2H-chromene derivatives bearing thiazolidine-2,4-dione, rhodanine or hydantoin moieties as potential anticancer agents. Azizmohammadi M; Khoobi M; Ramazani A; Emami S; Zarrin A; Firuzi O; Miri R; Shafiee A Eur J Med Chem; 2013 Jan; 59():15-22. PubMed ID: 23202485 [TBL] [Abstract][Full Text] [Related]
18. Review of anticancer potentials and structure-activity relationships (SAR) of rhodanine derivatives. Yin LJ; Bin Ahmad Kamar AKD; Fung GT; Liang CT; Avupati VR Biomed Pharmacother; 2022 Jan; 145():112406. PubMed ID: 34785416 [TBL] [Abstract][Full Text] [Related]
19. Screening methods for influenza antiviral drug discovery. Atkins C; Evans CW; White EL; Noah JW Expert Opin Drug Discov; 2012 May; 7(5):429-38. PubMed ID: 22435452 [TBL] [Abstract][Full Text] [Related]